Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00931866 · ClinicalTrials.gov registry record · Phase 3
Diclofenac Patch for Treatment of Acute Pain Due to Mild to Moderate Soft Tissue Injuries (TAPED)
A Phase 3 study, sponsored by Cerimon Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 407
- Enrollment target
NCT00931866 is a Phase 3 study that has completed, run by Cerimon Pharmaceuticals. The registered enrollment target is 407 participants.
The verdict
NCT00931866, a Phase 3 study, has completed, sponsored by Cerimon Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 407 participants
- Enrollment target
Study Summary
The primary purpose of this study is to assess the effectiveness of once daily application of a diclofenac sodium topical patch in reducing mild to moderate soft tissue injuries when applied to the painful area.
Interventions
- DRUG Matching Placebo Patch
- DRUG Diclofenac Sodium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 407 participants |
| Start Date | 2009-04 |
| Est. Completion | 2009-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00931866
The ClinicalTrials.gov registry entry for NCT00931866 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 407 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cerimon Pharmaceuticals, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Matching Placebo Patch is the first listed.
NCT00931866 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00931866 about?
NCT00931866 is a clinical study titled "Diclofenac Patch for Treatment of Acute Pain Due to Mild to Moderate Soft Tissue Injuries (TAPED)". The primary purpose of this study is to assess the effectiveness of once daily application of a diclofenac sodium topical patch in reducing mild to moderate soft tissue injuries when applied to the painful area.
What is the current status of trial NCT00931866?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 407 participants. The study started on 2009-04. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00931866?
The interventions under investigation include: Matching Placebo Patch (DRUG), Diclofenac Sodium (DRUG).
Who is sponsoring clinical trial NCT00931866?
This trial is sponsored by Cerimon Pharmaceuticals, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.